Murray Dallan bought SRPT
March 7, 2025 · Form 4 insider transaction
Murray Dallan bought 5,500 shares of Sarepta Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,500
Price
N/A
Total value
N/A
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 7, 2025
Filing dateMarch 11, 2025
Shares owned after33,659
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.